We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Alliance to Develop Optical Imaging Products

By HospiMedica staff writers
Posted on 18 Nov 2003
An alliance to develop optical imaging products for the laboratory market has been announced by Imaging Diagnostic Systems, Inc. More...
(IDSI, Fort Lauderdale, FL, USA) and the Rumbaugh-Goodwin Institute for Cancer Research, Inc. (Plantation, FL, USA).

IDSI, which has developed a breast imaging product, is now developing a new line of products based on the company's optical computed tomography (CT) and fluorescent imaging technologies, called Laser Imaging for Lab Animals (LILA). The first model is a miniature optical CT scanner for imaging green fluorescent protein, derived from the DNA of jellyfish. The Rumbaugh-Goodwin Institute has expertise in optical imaging for determining the efficacy of new anticancer treatments and spontaneously metastasizing models of human breast cancer. The institute's main goal is to develop cancer therapies targeting tumors, with minimal cellular damage and toxicity for the patient.

"With this agreement, IDSI is addressing a new market, targeting pharmaceutical developers and researchers who monitor cancer growth,” noted Linda Grable, CEO of IDSI. "It is exciting and beneficial to be adding a new product line to complement our breast imaging product.”






Related Links:
IDSI
Rumbaugh

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Next-Generation Sequencing Platform
AXELIOS 1 Platform
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.